On Friday, the FDA issued a warning to consumers, cautioning them against the use of certain over-the-counter eye drops from various brands, including CVS Health Corp (NYSE: CVS) and Cardinal Health Inc (NYSE: CAH).
The FDA's advisory stems from concerns that these eye drops may lead to eye infections and, in some instances, potential vision loss.
The agency's cautionary stance revolves around 26 OTC eye drop products, primarily designed to alleviate symptoms of dry eyes and relieve eye irritation.
This advisory follows a recent FDA warning to eight companies, including CVS and Walgreens Boots Alliance ...